Taiwan · Delayed Price · Currency is TWD Lumosa Therapeutics Statistics
Total Valuation
TPEX:6535 has a market cap or net worth of TWD 21.44 billion. The enterprise value is 20.70 billion.
| Market Cap | 21.44B |
| Enterprise Value | 20.70B |
Important Dates
The next estimated earnings date is Monday, May 18, 2026.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6535 has 167.49 million shares outstanding. The number of shares has increased by 1.68% in one year.
| Current Share Class | 167.49M |
| Shares Outstanding | 167.49M |
| Shares Change (YoY) | +1.68% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 1.34% |
| Owned by Institutions (%) | 6.57% |
| Float | 88.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 682.35 |
| PB Ratio | 15.27 |
| P/TBV Ratio | 15.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -58.15 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -62.37 |
Financial Position
The company has a current ratio of 7.37, with a Debt / Equity ratio of 0.00.
| Current Ratio | 7.37 |
| Quick Ratio | 6.22 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -1,757.84 |
Financial Efficiency
Return on equity (ROE) is -22.40% and return on invested capital (ROIC) is -11.29%.
| Return on Equity (ROE) | -22.40% |
| Return on Assets (ROA) | -10.25% |
| Return on Invested Capital (ROIC) | -11.29% |
| Return on Capital Employed (ROCE) | -20.92% |
| Weighted Average Cost of Capital (WACC) | 5.45% |
| Revenue Per Employee | 805,590 |
| Profits Per Employee | -9.13M |
| Employee Count | 39 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.13 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.76% in the last 52 weeks. The beta is 0.22, so TPEX:6535's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -17.76% |
| 50-Day Moving Average | 140.98 |
| 200-Day Moving Average | 189.29 |
| Relative Strength Index (RSI) | 45.26 |
| Average Volume (20 Days) | 244,907 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6535 had revenue of TWD 31.42 million and -356.04 million in losses. Loss per share was -2.13.
| Revenue | 31.42M |
| Gross Profit | 18.50M |
| Operating Income | -293.56M |
| Pretax Income | -361.95M |
| Net Income | -356.04M |
| EBITDA | -289.27M |
| EBIT | -293.56M |
| Loss Per Share | -2.13 |
Balance Sheet
The company has 747.43 million in cash and 5.20 million in debt, with a net cash position of 742.23 million or 4.43 per share.
| Cash & Cash Equivalents | 747.43M |
| Total Debt | 5.20M |
| Net Cash | 742.23M |
| Net Cash Per Share | 4.43 |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 8.33 |
| Working Capital | 782.48M |
Cash Flow
In the last 12 months, operating cash flow was -331.31 million and capital expenditures -668,000, giving a free cash flow of -331.98 million.
| Operating Cash Flow | -331.31M |
| Capital Expenditures | -668,000 |
| Depreciation & Amortization | 4.32M |
| Net Borrowing | -6.79M |
| Free Cash Flow | -331.98M |
| FCF Per Share | -1.98 |
Margins
| Gross Margin | 58.89% |
| Operating Margin | -934.37% |
| Pretax Margin | -1,152.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6535 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.68% |
| Shareholder Yield | -1.68% |
| Earnings Yield | -1.66% |
| FCF Yield | -1.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |